● I-Pharmacogenetics
-
I-CYP2C9 yabantu kunye ne-VKORC1 Gene Polymorphism
Le kit iyasebenza kwi-vitro qualitative discovery of polymorphism of CYP2C9*3 (rs1057910, 1075A>C) kunye ne-VKORC1 (rs9923231, -1639G>A) kwi-DNA ye-genomic yeesampuli zegazi lomntu.
-
I-CYP2C19 yoMntu yeGene Polymorphism
Le khithi isetyenziselwa ukukhangela umgangatho we-in vitro we-polymorphism ye-CYP2C19 yofuzo CYP2C19 * 2 (rs4244285, c.681G> A), CYP2C19 * 3 (rs4986893, c.636G> A), CYP2C12C19, c2485 (rs68) >T) kwi-genomic DNA yeesampuli zegazi lomntu.
-
ILeukocyte yomntu iAntigen B27 Nucleic Acid
Le kit isetyenziselwa ukufumanisa umgangatho we-DNA kwi-leukocyte ye-antigen subtypes ye-HLA-B * 2702, i-HLA-B * 2704 kunye ne-HLA-B * 2705.
-
MTHFR Gene Polymorphic Nucleic Acid
Le khithi isetyenziselwa ukufumanisa iindawo ezi-2 zokuguqulwa kofuzo lwe-MTHFR.Ikhithi isebenzisa igazi elipheleleyo lomntu njengesampulu yokuvavanya ukubonelela ngovavanyo lomgangatho wemo yokuguquka.Inokunceda oogqirha ukuba bayile izicwangciso zonyango ezifanelekileyo kwiimpawu zomntu ngamnye ukusuka kwinqanaba le-molecular, ukuze kuqinisekiswe impilo yezigulana ngowona mlinganiselo mkhulu.
